甲泼尼松龙联合施普善治疗急性视神经炎疗效探讨  

Clinical Effect Observation of Methylprednisolone Combined Cerebrolysin for Treatment of Acute Optic Neuritis (AON)

作　　者：刘桂香[1] 

机构地区：[1]河南煤化焦煤集团中央医院神经内一科,河南焦作454000

出　　处：《中外医疗》2013年第21期83-84,共2页China & Foreign Medical Treatment

摘　　要：目的甲泼尼松龙和施普善联用治疗急性视神经炎的研究探讨。方法选取来该院就诊的44例(74眼)病例,其中22例(37眼)给予甲泼尼松龙,标记为对照组。另外22例(37眼)加用施普善,标记为治疗组。两组疗程均为3周。结果疗程结束后,对照组22眼显效,9眼有效,6眼无效,总有效率为83.8%,治疗组26眼显效,9眼有效,2眼无效,总有效率94.6%,结果差异有统计学意义(P<0.05)。发病时间越短治愈率越高,结果差异有统计学意义(P<0.05)。结论相比之下,两种药物联用治疗急性视神经炎效果更好,安全可靠,有临床推广应用的价值。Objective To study and discuss the clinical effect of methylprednisolone combined cerebrolysin for treatment of AON. Methods Among 44 cases （74 eyes）, 22 cases （37 eyes） were given treatment of methylprednisolone and marked as control group. The other 22 cases （37 eyes） were given treatment of methylprednisolone combined cerebrolysin and marked as treatment group. Treatment course of both groups was 3 weeks. Results After treatment course, there were 22 eyes excellent, 9 eyes effective, and 6 eyes invalid in control group, total effective rate 83.8%; there were 26 eyes excellent, 9 eyes effective, and 2 eyes invalid in control group, total effective rate 94.6%（P〈0.05）. The shorter disease time was, the higher cure rate was （P〈0.05）. Conclusion Through comparison, combination of the two kinds of medicine has a better effect for treatment of AON, it＇s safe and reliable and has popularizing value in clinical work.

关 键 词：甲泼尼松龙 施普善 急性视神经炎 疗效 

分 类 号：R774.6[医药卫生—眼科]